Asia Pacific Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis

List of Tables

The Asia Pacific endothelial dysfunction market is expected to grow from US$ 304.48 million in 2022 to US$ 405.51 million by 2028. It is estimated to grow at a CAGR of 4.9% from 2022 to 2028.

Rising Usage of Novel Biomarkers and Therapeutic Strategies Fuels Asia Pacific Endothelial Dysfunction Market

Examining endothelial function can improve risk stratification, improve early disease detection, and assess vascular response to therapeutic interventions. There are studies to understand the pathophysiological mechanisms underlying endothelial dysfunction and atherosclerosis progression in a better way and identify new biomarkers and therapeutic strategies to prevent endothelial dysfunction and atherosclerosis to reduce the risk of developing coronary artery disease (CAD) and related complications. Using liquid biopsies and new molecular biology techniques has enabled the identification of a growing list of molecular and cellular markers of endothelial dysfunction that have provided insight into the molecular basis of atherosclerosis as well as potential biomarkers and therapeutic targets for the prevention and treatment of atherosclerosis and CAD.

Research on biomarkers and their clinical application has increased exponentially over the last few decades. Invaluable insight into the pathophysiology of atherosclerosis and the development of novel therapies have been provided by systemic biomarkers. Endothelial dysfunction and inflammation play a central role in the development and progression of CAD. Inflammatory mediators are secreted by inflammatory and vascular cells in atherosclerotic plaque or by organs such as the liver or adipose tissue.

Asia Pacific Endothelial Dysfunction Market Overview

The endothelial dysfunction market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the market in the region is attributed to the increasing cases of endothelial dysfunction with the rising incidence of CVD, hypertension, diabetes, and chronic diseases, coupled with the growing aging population. In addition, the market is driven by increasing investments in diagnostics techniques by the respective country governments, resulting in advancements in diagnostics methods.

Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Endothelial Dysfunction Market Segmentation

The Asia Pacific endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the Asia Pacific endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, Behcet's disease, and others. The hypertension segment registered the largest Asia Pacific endothelial dysfunction market share in 2022.

Based on test type, the Asia Pacific endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Asia Pacific endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the Asia Pacific endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Asia Pacific endothelial dysfunction market share in 2022.

Based on country, the Asia Pacific endothelial dysfunction market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific endothelial dysfunction market in 2022.

ZOLL Medical Corp, Sphingo Tec GmbH, Perimed AB, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Product Code: BMIRE00029598

Table of Content

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Asia Pacific Endothelial Dysfunction Market - by Cause
- 1.3.2 Asia Pacific Endothelial Dysfunction Market - by Test Type
- 1.3.3 Asia Pacific Endothelial Dysfunction Market - by End User
- 1.3.4 Asia Pacific Endothelial Dysfunction Market - by Country

2. Asia Pacific Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Endothelial Dysfunction Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis
4.3 Expert Opinion

5. Asia Pacific Endothelial Dysfunction Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Incidences of Cardiovascular Diseases
- 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
5.2 Market Restraints
- 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
5.3 Market Opportunities
- 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
5.4 Future Trends
- 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
5.5 Impact Analysis

6. Endothelial Dysfunction Market - Asia Pacific Analysis

6.1 Asia Pacific Endothelial Dysfunction Market Revenue Forecast and Analysis

7. Asia Pacific Endothelial Dysfunction Market Analysis - by Cause

7.1 Overview
7.2 Asia Pacific Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
7.3 Hypertension
- 7.3.1 Overview
- 7.3.2 Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.4 Diabetes
- 7.4.1 Overview
- 7.4.2 Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.5 Hypercholestrolaemia
- 7.5.1 Overview
- 7.5.2 Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.6 Behcet's Disease
- 7.6.1 Overview
- 7.6.2 Behcet's Disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.7 Obesity
- 7.7.1 Overview
- 7.7.2 Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Endothelial Dysfunction Market Analysis - by Test Type

8.1 Overview
8.2 Asia Pacific Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
8.3 Invasive Tests
- 8.3.1 Overview
- 8.3.2 Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Invasive Tests
- 8.4.1 Overview
- 8.4.2 Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.3 Flow Mediated Dilatory
  - 8.4.3.1 Overview
  - 8.4.3.2 Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.4 Venous Occlusion Plethysmography
  - 8.4.4.1 Overview
  - 8.4.4.2 Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.5 Peripheral Arterial Tonometry (PAT)
  - 8.4.5.1 Overview
  - 8.4.5.2 Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.6 Circulating Markers
  - 8.4.6.1 Overview
  - 8.4.6.2 Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.7 Others
  - 8.4.7.1 Overview
  - 8.4.7.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Endothelial Dysfunction Market Analysis - by End User

9.1 Overview
9.2 Asia Pacific Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostics Centers
- 9.4.1 Overview
- 9.4.2 Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.5 Clinics
- 9.5.1 Overview
- 9.5.2 Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Asia Pacific: Endothelial Dysfunction Market
- 10.1.1 Overview
  - 10.1.1.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.1.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.1.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.1.1.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.1.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.1.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.1.1.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.1.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.1.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.1.1.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.1.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.1.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.1.1.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.1.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.1.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.1.1.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.1.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.1.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.1.1.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Asia Pacific Endothelial Dysfunction Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Endothelial Dysfunction Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 ZOLL Medical Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sphingo Tec GmbH
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Perimed AB
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Medizinische Messtechnik GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms